204 related articles for article (PubMed ID: 30452655)
21. Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
Poulin R; Baker D; Poirier D; Labrie F
Breast Cancer Res Treat; 1989 Mar; 13(2):161-72. PubMed ID: 2525057
[TBL] [Abstract][Full Text] [Related]
22. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
Fraser IS
Contraception; 1983 Oct; 28(4):385-97. PubMed ID: 6230212
[TBL] [Abstract][Full Text] [Related]
23. Long-acting hormonal contraceptives for women.
Garza-Flores J; Hall PE; Perez-Palacios G
J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
[TBL] [Abstract][Full Text] [Related]
24. Counting the costs: comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa.
Smit J; Gray A; McFadyen L; Zuma K
BMC Health Serv Res; 2001; 1():4. PubMed ID: 11401729
[TBL] [Abstract][Full Text] [Related]
25. Clinical experience with injectable progestogen- only contraceptives at University of Ilorin teaching hospital: a five year review.
Balogun OR; Raji HO
Niger Postgrad Med J; 2009 Dec; 16(4):260-3. PubMed ID: 20037621
[TBL] [Abstract][Full Text] [Related]
26. Acceptability of injectable contraceptives in Assiut, Egypt.
Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
[TBL] [Abstract][Full Text] [Related]
27. The source of Mycobacterium tuberculosis-specific IFN-γ production in peripheral blood mononuclear cells of TB patients.
Wang F; Mao L; Hou H; Wu S; Huang M; Yin B; Huang J; Zhu Q; Pan Y; Sun Z
Int Immunopharmacol; 2016 Mar; 32():39-45. PubMed ID: 26796515
[TBL] [Abstract][Full Text] [Related]
28. Medroxyprogesterone acetate-treated human, primary endometrial epithelial cells reveal unique gene expression signature linked to innate immunity and HIV-1 susceptibility.
Woods MW; Zahoor MA; Dizzell S; Verschoor CP; Kaushic C
Am J Reprod Immunol; 2018 Jan; 79(1):. PubMed ID: 29105931
[TBL] [Abstract][Full Text] [Related]
29. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract.
Africander D; Louw R; Verhoog N; Noeth D; Hapgood JP
Contraception; 2011 Oct; 84(4):423-35. PubMed ID: 21920200
[TBL] [Abstract][Full Text] [Related]
31. Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception.
Draper BH; Morroni C; Hoffman M; Smit J; Beksinska M; Hapgood J; Van der Merwe L
Cochrane Database Syst Rev; 2006 Jul; (3):CD005214. PubMed ID: 16856087
[TBL] [Abstract][Full Text] [Related]
32. Increased HIV-1 infection in PBMCs treated in vitro with menstrual cycle phase hormones or medroxyprogesterone acetate likely occurs via different mechanisms.
Bick AJ; Avenant C; Tomasicchio M; van der Spuy Z; Hapgood JP
Am J Reprod Immunol; 2022 Dec; 88(6):e13643. PubMed ID: 36302121
[TBL] [Abstract][Full Text] [Related]
33. Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa.
Smit J; McFadyen L; Zuma K; Preston-Whyte E
Soc Sci Med; 2002 Nov; 55(9):1511-22. PubMed ID: 12297238
[TBL] [Abstract][Full Text] [Related]
34. Increased Cervical CD4
Lajoie J; Tjernlund A; Omollo K; Edfeldt G; Röhl M; Boily-Larouche G; Cheruiyot J; Kimani M; Kimani J; Oyugi J; Broliden K; Fowke KR
AIDS Res Hum Retroviruses; 2019 Mar; 35(3):236-246. PubMed ID: 30585733
[TBL] [Abstract][Full Text] [Related]
35. Bleeding patterns of women using Lunelle monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other oral contraceptives.
Garceau RJ; Wajszczuk CJ; Kaunitz AM;
Contraception; 2000 Dec; 62(6):289-95. PubMed ID: 11239615
[TBL] [Abstract][Full Text] [Related]
36. A study of adrenal corticol function and its reserve activity in long-acting injectable contraceptive users.
Amatayakul K; Petpoo W; Ratanawananukul N; Tanthayaphinant O; Tovanabutra S; Suriyanon V
Contraception; 1988 May; 37(5):483-92. PubMed ID: 2970367
[TBL] [Abstract][Full Text] [Related]
37. Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
Koetsawang S
Contraception; 1994 Apr; 49(4):387-98. PubMed ID: 8013221
[TBL] [Abstract][Full Text] [Related]
38. Injectable contraceptives: a worldwide perspective.
Affandi B
J Fam Plann Reprod Health Care; 2002 Jan; 28(1):3-4. PubMed ID: 16259804
[No Abstract] [Full Text] [Related]
39. [Injectable contraception using depot progestagens].
Velasco Murillo V; Correu Azcona S
Ginecol Obstet Mex; 1983 Jul; 51(315):191-7. PubMed ID: 6242048
[TBL] [Abstract][Full Text] [Related]
40. Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.
Haiba NA; el-Habashy MA; Said SA; Darwish EA; Abdel-Sayed WS; Nayel SE
Contraception; 1989 Jun; 39(6):619-32. PubMed ID: 2666019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]